Oragenics, Inc.
OGEN
$0.85
$0.000.01%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 930.90K | 449.70K | 341.50K | 1.67M | 879.00K |
| Gross Profit | -930.90K | -449.70K | -341.50K | -1.67M | -879.00K |
| SG&A Expenses | 2.19M | 1.26M | 1.68M | 1.69M | 1.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.12M | 1.71M | 2.03M | 3.36M | 2.44M |
| Operating Income | -3.12M | -1.71M | -2.03M | -3.36M | -2.44M |
| Income Before Tax | -3.07M | -2.27M | -2.22M | -3.35M | -2.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.07M | -2.27M | -2.22M | -3.35M | -2.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.07M | -2.27M | -2.22M | -3.35M | -2.46M |
| EBIT | -3.12M | -1.71M | -2.03M | -3.36M | -2.44M |
| EBITDA | -- | -- | -- | -3.35M | -2.43M |
| EPS Basic | -1.96 | -3.10 | -3.65 | -8.43 | -11.32 |
| Normalized Basic EPS | -1.23 | -1.94 | -2.28 | -5.27 | -7.07 |
| EPS Diluted | -1.96 | -3.10 | -3.65 | -8.43 | -11.32 |
| Normalized Diluted EPS | -1.23 | -1.94 | -2.28 | -5.27 | -7.07 |
| Average Basic Shares Outstanding | 1.56M | 731.80K | 607.10K | 397.20K | 217.60K |
| Average Diluted Shares Outstanding | 1.56M | 731.80K | 607.10K | 397.20K | 217.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |